Each manufacturer shall establish and maintain procedures for identifying product during all stages of receipt, production, distribution, and installation to prevent mixups.
21 CFR Part 820 · Quality Management System Regulation
§ 820.60 Identification
Independent copy, not an official legal edition. 21 CFR is a U.S. Government work in the public domain; this text comes from the eCFR and the annual CFR edition, and may lag recent amendments. The authoritative version is on ecfr.gov. Compliome is not affiliated with or endorsed by FDA. Not legal advice.
What FDA inspectors cite under § 820.60
Form FDA 483 observations citing this section, fiscal years 2009–2025 (Devices).
- Identification procedures, Lack of or inadequate procedures 119
Warning letters citing § 820.60
4 FDA warning letters since 2017 cite this section :
- Hong Qiangxing Shenzhen Electronics Limited 28 Oct 2025
- LEVO AG 18 Jul 2025
- W.H.P.M, Inc. 30 Jun 2022
- X12 Co., LTD. 23 Mar 2017